Merck & Co., Inc. (MRK)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
79.83+0.62 (+0.78%)
At close: 4:02PM EDT
| Previous close | 79.21 |
| Open | 79.26 |
| Bid | 79.86 x 800 |
| Ask | 80.00 x 1300 |
| Day's range | 79.26 - 80.62 |
| 52-week range | 65.25 - 92.64 |
| Volume | 6,785,564 |
| Avg. volume | 7,959,812 |
| Market cap | 201.909B |
| Beta (5Y monthly) | 0.45 |
| PE ratio (TTM) | 19.45 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 2.44 (3.06%) |
| Ex-dividend date | 14 Sep 2020 |
| 1y target est | N/A |
- Business Wire
Merck Donates $500,000 to Support River Blindness and Lymphatic Filariasis Elimination Efforts
Merck Donates $500,000 to Support River Blindness and Lymphatic Filariasis Elimination Efforts
- Business Wire
Merck to Present New Data from its Extensive Infectious Diseases and Vaccines Pipeline and Portfolio During IDWeek 2020
Merck to Present New Data from its Extensive Infectious Diseases and Vaccines Pipeline and Portfolio During IDWeek 2020
- Business Wire
Merck Announces Positive Topline Results from Two Additional Phase 3 Adult Studies Evaluating V114, Merck’s Investigational 15-valent Pneumococcal Conjugate Vaccine
Merck Announces Positive Topline Results from 2 Ph3 Adult Studies Evaluating V114, Merck’s Investigational 15-valent Pneumococcal Conjugate Vaccine
© 2020 Verizon Media. All rights reserved.
